Search Results

Diremia: Our partners OUR PARTNERS Η Diremia Ltd έχει άριστη συνεργασία με την εταιρεία ENTOS, γνωστή σε όλη την Ελλάδα για μεγάλη γκάμα ποιοτικών προϊόντων, που πωλούνται από τα δικά της καταστήματά και μέσω αντιπροσώπων σε πολλά μέρη της χώρας. Τ ο Entos δημιουργήθηκε το 2006 από ανθρώπους που πιστεύουν ότι όλοι έχουν δικαίωμα να φτιάξουν το σπίτι που ονειρεύονται. Από τότε μέχρι σήμερα παρουσιάζουμε μοναδικές συλλογές υψηλής αισθητικής και design σε πολύ προσιτές τιμές για το καθιστικό, την κρεβατοκάμαρα, την τραπεζαρία, το home office και τα αξεσουάρ. Συνεργαζόμαστε με την εταιρία στρωμάτων της Αμερικής SERTA και με άλλες παγκοσμίου φήμης εταιρίες αλλά και με τους καλύτερους εγχώριους κατασκευαστές, και διαθέτουμε την πιο ολοκληρωμένη πρόταση της αγοράς. Με 30 καταστήματα σε όλη την Ελλάδα και το e-shop μας και με 30.000 κωδικούς προϊόντων στη συλλογή μας μπαίνουμε σε όλα τα ελληνικά σπίτια και κάνουμε πραγματικότητα τα όνειρα των πελατών μας Diremia Ltd is proud to have as a partner, Mr Kyriacos Kangellaris, a highly experienced, CISI Level 6-qualified front-office market professional with over two decades in the financial industry, . Mr Kangellaris is skilled across Equities, Bonds, Futures, Commodities, FX, Options, and Derivatives, Kyri has built a strong track record in B2B and B2C financial sales, client relationship management, and institutional business development. Currently a Director of Alexander Financial Ltd. . Previous roles include senior positions at Finseta, Horizon Stockbroking, and Strand Capital, where he contributed to strategic growth, compliance leadership, and product innovation. Fluent in English and Greek, Kyri holds a BSc (Hons) in Mathematics and Statistics from the University of London and is recognized for his analytical acumen, market insight, and client-focused approach. Health and Iasis has been formed via a spin off from a larger multi product group structure with an intent and scope of focusing strictly with the Orthopaedics segment. All the people supporting this venture are of high caliber with long standing experience in Orthopaedics in terms of product mix but also having an immense experience in market presence spanning over 20 years. In addition, we would like to assure you that our company has secure financial foundations with no historical debts weighing on its balance sheet. Over the past 3-4 years, the segment but also the medical devices market in Greece has undergone a major restructuring from processes to suppliers currently active. The Greek Orthopaedics market is now a lot more mature now and due to the ongoing demographic problem, we believe that it has very good growth potential for many more years to come. Company's Vision The Company’s vision is to provide high-quality medical devices that meet the specialized needs of patients. Company Objectives Prompt response to the needs of patients and their physicians Provision of a wide range of materials suitable for specialized procedures Immediate and effective service to both patients and healthcare professionals Full compliance with Greek and European legislation Management and Staff are committed to: Continuous training of personnel for the company's products and materials Collaboration with reliable and reputable manufacturers Constant modernization of the company’s equipment and facilities Continuous improvement of the Quality Management System Ongoing enhancement of customer satisfaction CONTACT DETAILS Address: Anapafseos 30, Vrilissia, Athens, Greece Phone: +30 2155 51590608 Fax: +30 2155 515910 Email: info @ health-iasis . net Website: www.health-iasis.net/en/ PARTNER WITH US Partnerships are integral to the success of our business, enabling us to achieve economies of scale, introduce significant volumes of business, and secure the most competitive rates and services for our valued clients. Our discerning approach to selecting partners and supplier firms ensures that we maintain the highest standards of service delivery, further enhancing our reputation. Rest assured, your clients and you will receive nothing short of the very best in service excellence. OUR SERVICES Corporate Client Services Access quick and easy international payments and foreign exchange with us. We offer your organisation better rates and reduced costs when compared to banks and even other currency brokers. FX deals direct with dedicated account manager or on online trading platform Manage beneficiaries easily or with your account manager. Upload bulk regular beneficiaries and payments View transaction history, balances, statements. Forward FX contracts to reduce exposure to future currency fluctuations. Personal Client services Access quick and easy international payments and foreign exchange with us. We are not a bank, which means we can offer a more local and personal service – and more competitive rates. We promise to strip away the unnecessary jargon and keep things simple, so you know exactly what you’re getting for your money with complete unparalleled transparency. Save money with our clear pricing, easy system and fast settlements, Access to personal support whenever you need it. View transaction history, balances and statements. Alexfin.com is a trading name of Alexander Financial Ltd. which is a company registered in England and Wales Company No.06235873 with a registered address of 36 Beechfield Road, Welwyn Garden City, AL7 3RF. CONTACT DETAILS Phone: +44 7958 245 949, +44 330 043 8858 Email: info@alexfin.com Website: www.alexfin.com Who Are We? Who Are We? Who Are We? Who Are We? Who Are We? Who Are We? Search Results

Diremia: About Us ABOUT US Diremia Ltd is a boutique sales, marketing, and business development consultancy. We help individuals and organisations grow with clarity, credibility, and the right partnerships. We are headquartered in Nicosia, Cyprus, and work with clients and associates across European and Middle East regions. LEADERSHIP, PARTNERS, & ADVISERS CEO Vangelis Dimas, actively engages with developments in sustainable finance and the broader financial ecosystem through international conferences and industry forums. We work with a network of partners and advisers including: Kyriacos Kangellaris, qualified financial professional with experience across equities, bonds, FX and derivatives. Christina Ioannou, with international cultural and PR experience, provides communications and advisory. Konstantinos Aslanoglou, Legal Advisor & Business Consultant, with experience in cross border business provides legal and commercial advisory support. WHAT WE DO We support companies with practical, hands-on help across the commercial lifecycle, including: Go-to-market strategy & positioning B2B / institutional sales support and relationship-led business development- Partnership building (introductions, commercial structuring, and scaling via trusted counterparties) Marketing direction that connects the story to measurable growth WHERE WE FOCUS Our team has expertise and network in the following sectors: Financial markets, funds and alternative investments. Cross-border solutions, including access to international payments and FX conversion and forward FX contracts. Selected specialist sectors, including medical devices (orthopedics), arts/culture and PR communications, homeware products. HOW WE WORK We select and cooperate with only with reliable and partners and associates who deliver results for our clients. Our business model is built around combining a client-focused core with a curated network of partners and advisers so clients get specialist input with customized service and reasonable cost. Our team has expertise and network in the following sectors: Financial markets, funds and alternative investments. Cross-border solutions, including access to international payments and FX conversion and forward FX contracts. Selected specialist sectors, including medical devices (orthopedics), arts/culture and PR communications, homeware products. GET IN TOUCH If you want to discuss a growth challenge, a market entry, or a partnership opportunity, email or call us today! Email: info@diremia.com, Mobile/WhatsApp: +30 6944 420027 Who Are We? Who Are We? Who Are We? Who Are We? Who Are We? Who Are We? Search Results

Diremia: News and updates NEWS & UPDATES 11th International Funds Summit & Expo, Parklane Resort and Spa, Limassol, Cyprus Ημερομηνία 10.11.25 Summit Insights & Presentations Our CEO, Vangelis Dimas, participated as in the 11th International Funds Summit and Expo with focus on The European Alternative Funds Landscape held at the Parklane Hotel, Luxury Collection Resort and Spa, Limassol, Cyprus, organized by Invest Cyprus and Cyprus Investment Funds Association (CIFA). The summit is recognised as premier annual gathering for professionals in the funds and asset management industry, offering an in-depth analysis of the latest trends, regulatory updates, and emerging opportunities within the sector. This event was an opportunity for Mr Dimas to meet a distinguished group of fund managers, institutional investors, policymakers, and industry experts from around the world. Keynote addresses were from George Theocharous, Chairman of the Cyprus Securities and Exchange Commission (CySEC) and Michael Fekkas, Vice Chair of the Hellenic Capital Market Commission. Interesting topics in the agenda included the Role of Non Traditional Asset Classes, Private Markets, Private Credit, AIFs Capital Raising, Cross Border Platforms, Innovative Digital Onboarding, Growing European PE and VC Opportunities, ESG Integration and Strategic Allocation, Semi Liquid Private Equity, and Building Bridges In Alternative Investments India-Cyprus. "Εύπορες Οικογένειες: Ψάχνουν πώς θα διαχειριστούν τον πλούτο. Ήρθαν και στην Κύπρο τα «Family Offices» Αρθρό του Χαράλαμπου Ζάκο στο Philenews Ημερομηνία 09.11.25 Η Κύπρος ανοίγει νέα σελίδα στη διαφοροποίηση της οικονομίας, με την προσέλκυση των «Family Offices», ή πιο σωστά στα ελληνικά: Γραφεία Διαχείρισης Οικογενειακού Πλούτου. Τις προηγούμενες ημέρες πραγματοποιήθηκε στη Λεμεσό υψηλού επιπέδου εκδήλωση, συγκεντρώνοντας βασικούς φορείς από τον χρηματοοικονομικό, ρυθμιστικό και ιδιωτικό τομέα διαχείρισης περιουσίας, για να συζητήσουν το μέλλον των «Family Οffices» στη χώρα. READ THE ARTICLE IN ENGLISH Image credit: Philenews/In-Cyprus Online Γιάννης Κανταρτζής "Επένδυσε Τώρα. Μ’ ευχαριστείς μετά." Ημερομηνία 06.11.25 Η καλύτερη στιγμή να ξεκινήσεις να επενδύεις ήταν πριν από 25 χρόνια. Η δεύτερη καλύτερη είναι πάντα σήμερα. Άσε κάτω το κινητό και ξεκίνα να διαβάζεις το βιβλίο. Τι περιμένεις; Τόσα χρόνια σου λένε να δουλεύεις, να αποταμιεύεις και «όλα θα πάνε καλά». Πήγαν; Η απάντηση είναι προφανώς και όχι. Το βιβλίο αυτό γράφτηκε για όλους αυτούς τους ανθρώπους που δουλεύουν σκληρά, που έχουν άγχος για το αύριο, που νιώθουν ότι «δεν τους φτάνουν τα λεφτά» κι ας προσπαθούν. Γράφτηκε και για εκείνους που ψάχνουν πώς να επενδύσουν σωστά τα χρήματά τους. Ο συγγραφέας δεν υπόσχεται μαγικές λύσεις και εύκολο πλουτισμό. Θα σου δείξει όμως πώς να βγεις από τον λαβύρινθο και να σταματήσεις να είσαι αιχμάλωτος του μισθού σου. «Μέσα από καθημερινά παραδείγματα και αληθινές ιστορίες, προσπάθησα να κάνω τον κόσμο των επενδύσεων κατανοητό, ανθρώπινο και πρακτικό. Όχι σαν θεωρία, αλλά σαν τρόπο ζωής. Σαν μια διαδρομή προς την ηρεμία, την αυτονομία και τη σταθερότητα. Το μόνο που έχεις να κάνεις είναι απλώς να ξεκινήσεις τώρα». Περισσότερο Για Τον Συγγραφέα Christina Chara Ioannou, Founder, Director & Campaign Lead CCIcomms 2025 Q3|Q4 Highlights Ημερομηνία 05.11.25 We are delighted to celebrate a vibrant and collaborative season marked by creative partnerships, cultural dialogue, and strategic growth. This quarter saw the launch of our new collaboration with Natura Greca, the Swiss travel agency designing immersive journeys through Greece, blending heritage and immersive travel experiences in the Mediterranean. Vangelis Dimas, CEO, Diremia @ International Funds Summit & Expo Ημερομηνία 04.11.25 Date: 04.11.25 Our CEO, Vangelis Dimas, participated as in the 11th International Funds Summit and Expo with focus on The European Alternative Funds Landscape held at the Parklane Hotel, Luxury Collection Resort and Spa, Limassol, Cyprus, organized by Invest Cyprus and Cyprus Investment Funds Association (CIFA). The summit is recognised as premier annual gathering for professionals in the funds and asset management industry, offering an in-depth analysis of the latest trends, regulatory updates, and emerging opportunities within the sector. This event was an opportunity for Mr Dimas to meet a distinguished group of fund managers, institutional investors, policymakers, and industry experts from around the world. Keynote addresses were from George Theocharous, Chairman of the Cyprus Securities and Exchange Commission (CySEC) and Michael Fekkas, Vice Chair of the Hellenic Capital Market Commission. Interesting topics in the agenda included the Role of Non Traditional Asset Classes, Private Markets, Private Credit, AIFs Capital Raising, Cross Border Platforms, Innovative Digital Onboarding, Growing European PE and VC Opportunities, ESG Integration and Strategic Allocation, Semi Liquid Private Equity, and Building Bridges In Alternative Investments India-Cyprus. List of Speakers @ Summit Κωνσταντίνος Ν. Σεγρεδάκης "Η κρίσιμη διαφορά μεταξύ μικτού περιθωρίου κέρδους και mark up" Ημερομηνία 31.10.25 Η μαθηματική «παγίδα» που μπερδεύει τους επιχειρηματίες και «κλέβει» την κερδοφορία. Πότε χρησιμοποιείται το μικτό περιθώριο κέρδους και πότε το Mark Up. Στο συνδεσμό πιο κάτω θα βρείτε το πρόσφατο άρθρο του Κων. Σεγρεδάκη στο euro2day. Vangelis Dimas, CEO, Diremia @ Adaptation & Resilience Training Workshop Ημερομηνία 24.10.25 Our CEO, Vangelis Dimas, participated as in the Adaptation and Resilience Training Workshop, organized during the Climate Bonds Connect conference in London, which was held at the offices of Ashurst, Fruit & Wool Exchange, 1 Duval Square, London, E1 6PW. The workshop agenda was very interesting and included below topics: The workshop agenda was very interesting and included below topics: - How to assess credibility and ambitions of corporate transition plans - Tools and frameworks to assess transition plans of companies - How to assess a company’s low emissions strategy - Different methodologies for transition finance - Current regulatory landscape and practical implementation strategies - Defining credible adaptation & resilience (A&R) investments - Practical tools to assess what constitutes a credible A&R investment - Basics of investment integration and risk analysis Why Is A & R Important ? Vangelis Dimas, CEO, Diremia @ Climate Bonds CONNECT Conference Ημερομηνία 24.10.25 Vangelis Dimas, CEO Diremia Cyprus, participated as a delegate at the Climate Bonds CONNECT 2025 global conference, which took place at The Brewery, 52 Chiswell Street, London EC1Y 4SA, United Kingdom. This was an opportunity to learn about the new trends and opportunities at the forefront of sustainable investments and finance. The event gathered key players from the financial sector, government authorities, and corporations to discuss the most pressing issues of our time. The speakers dived deep into how sustainable finance is evolving in today’s shifting economic and geopolitical landscape. From national investment strategies to regional economic trends, from investor priorities to the transformation of financial institutions, they discussed how climate-driven regulation is reshaping the financial system. Publications & Insights Κωνσταντίνος Ν. Σεγρεδάκης "Γιατί το ΔΝΤ φοβάται βουτιά στις αγορές" Ημερομηνία 20.10.25 Η αντίθεση μεταξύ του εφησυχασμού των αγορών και των αυξημένων μακροοικονομικών και γεωπολιτικών κινδύνων. Το discount της Ευρώπης έναντι των ΗΠΑ. Τα επιτόκια και η επίδραση της AI. Στο σύνδεσμο που ακολουθεί θα βρείτε το πρόσφατο άρθρο του Κων. Σεγρεδάκη στο euro2day. "Understanding Digital Marketing: Key Types, Channels, and Examples", Investopedia Written by Investopedia team, reviewed by Margaret James, fact checked by Yarilet Perez Ημερομηνία 28.09.25 Digital marketing utilizes online platforms, including websites, apps, social media, and search engines, to promote products, establish brand awareness, and engage consumers. Emerging in the 1990s with the rise of the internet, it now works alongside traditional marketing. Marketers benefit from the data-driven insights of digital marketing, but also face challenges from the rapidly evolving digital channels and the pace required to keep up. Image credit: Investopedia / Mira Norian Vangelis Dimas, CEO, Diremia @ Artemis London CAT & ILS Conference Ημερομηνία 04.09.25 Our CEO, Vangelis Dimas, participated as a delegate at the fourth insurance linked securities (ILS) conference organized by Artemis. The London CAT Bond & ILS Conference held at the on 2nd September 2025 in the City of London at The Minster Building, 21 Mincing Lane, London EC3R 7AG. Mr Vangelis had the opportunity to meet many of the over 220 attendees and had interesting discussions as well as valuable networking with industry experts, re/insurance market leaders and investors. There was a full-day of detailed discussions on catastrophe bonds and the wider insurance-linked securities (ILS) market and useful presentations exploring ILS market priorities for the reinsurance renewals at the end of the year. This was a great event to hear industry thought-leaders, ILS fund managers, and to discuss trends in the insurance-linked securities (ILS) market, capital markets future role in reinsurance, and the ILS investment opportunity. Review of the conference "Understanding Marketing in Business: Key Strategies and Types", Investopedia Written by Alexandra Twin, reviewed by David Kindness, fact checked by Ariel Courage Ημερομηνία 18.07.25 Image credit: Investopedia / Lara Antal Marketing encompasses all the activities that a company undertakes to promote and facilitate the buying or selling of its products or services. This critical business function involves advertising and other promotional strategies aimed at reaching consumers, other businesses, and organizations. In a company, marketing professionals focus on capturing the attention of target audiences through a variety of methods, including celebrity endorsements, engaging slogans, eye-catching designs, and expansive media coverage. Their ultimate goal is to connect a company's products with its intended market, ensuring both business growth and customer satisfaction. "What is digital marketing?", by Oracle . com Ημερομηνία 18.06.25 Digital marketing refers to the creation and dissemination of content through digital media channels—websites, landing pages, social media, email, and mobile applications—and the promotion of that content using a variety of strategies across paid, earned, and owned digital channels, including SEO, SEM, pay-per-click (PPC) advertising, content syndication, social, email, text, and more. "AI Will Shape the Future of Marketing?", Harvard University Division of Continuing Education Written by Melissa Russell and Christina Inge Ημερομηνία 14.04.25 From chatbots to social media management to full-scale marketing campaigns and automation, artificial intelligence is changing the way marketers do their jobs. Routine tasks like writing copy, mining consumer data, and creating visuals that once took hours can now be done in minutes. Businesses should view AI as an opportunity to provide more customized and relevant marketing experiences for their customers and ultimately drive their business forward. Image credit: Harvard DCE Who Are We? Who Are We? Who Are We? Who Are We? Who Are We? Who Are We? Search Results

Diremia: Our Advisers OUR ADVISERS Christina Chara Ioannou Art & Cultural Advisor Christina Chara Ioannou is a Senior Communications and PR Strategist with over a decade of experience shaping international narratives across the arts, culture, and creative industries. As Founder and Director of CCIcomms Ltd, an award-winning PR and communications boutique, Christina has led more than 50 international arts and cultural projects, supporting leading institutions, artists, and brands in defining and amplifying their global presence. sector. Before establishing her own agency, Christina held senior positions with renowned organisations including Brunswick Arts, Art Basel, FIAC, London Design Biennale and the Venice Biennale, among others. Her work spans the wider lifestyle, design, and luxury sectors, combining strategic insight with a nuanced understanding of the global media landscape and art market trends. Known for her critical eye, collaborative leadership, and solution-oriented approach, Christina helps cultural leaders and founders articulate their vision and strengthen their brand identity in an evolving creative economy. In addition to her advisory work, Christina contributes to Entrepreneur.com on topics related to the arts and creative industries. She is also a mentor to students at the University of London and serves on several boards, where she focuses on public relations and marketing strategy within the cultural sector. Contact Information: Mobile/WhatsApp: +41 (0) 772457466 | +44 (0) 7447997215 Website: www.ccicomms.com Book a Call: On Calendly Konstantinos Aslanoglou Legal Advisor & Business Consultant Konstantinos Aslanoglou was born in Athens, Greece and graduated in 1988 with a Diploma with honors, from the Legal Department of the Democritus University of Thrace. Since graduation he has worked as a licensed lawyer in Athens, Greece and in Sofia, Bulgaria, specializing in Immigration Law. From 2008 to 2011, he was Legal Representative and Manager in Perla, a company dealing with transfers between Greece, Turkey and Romania. From 2011 to 2012, he was Legal Advisor and Coordinator in Praxis Investments SA. During his professional career, Mr Aslanoglou, has developed valuable skills such as: • expertise in commercial contracts, especially for software and technology industries • deep and up to date knowledge of corporate, business and privacy laws • extensive experience in law firms and in corporate in-house environments • good drafting, negotiating and supervision skills • excellent written and verbal communication and people skills • good customer service approach and mindset • maintain diplomacy and respect confidentiality with associates and clients • language skills: Greek: perfect, English: Good, Bulgarian: Good Contact Information: Mobile/WhatsApp: +359 887 977 486 Email: aslanoglouklawyer@gmail.com Who Are We? Who Are We? Who Are We? Who Are We? Who Are We? Who Are We? Search Results

Diremia: Contact details CONTACT US For more information about our services or to discuss potential cooperation, fill in the form below so we can contact you as soon as possible First name* Last name Email* Phone Tell us what you are interested in ? Submit

Diremia Sales and Consulting Services For more information about our services or to discuss potential cooperation, fill in the form below so we can contact you as soon as possible First name* Last name Email* Phone Tell us what you are interested in ? Submit

GYNECOLOGIST . OBSTETRICIAN . IN VITRO FERTILISATION DNA METABOLISM . ANTI-AGING TREATMENTS PREVENTIVE MEDICINE OUR SERVICES Gynaecology We provide compassionate health care combined with advanced medical and technical expertise. Our patient-focused, multi-lingual (Russian, English, Greek) health care team collaborates with selected experts and consultants who specialize in: Gynaecology, Family Medicine, Child Care, Breast Health, Anti-aging Treatments, Preventive Medicine, Plastic Surgery, Aesthetic Medicine, Complementary Medicine, and Alternative medicine. Read More In Vitro Fertilisation We provide compassionate health care combined with advanced medical and technical expertise. Our patient-focused, multi-lingual (Russian, English, Greek) health care team collaborates with selected experts and consultants who specialize in: Gynaecology, Family Medicine, Child Care, Breast Health, Anti-aging Treatments, Preventive Medicine, Plastic Surgery, Aesthetic Medicine, Complementary Medicine, and Alternative medicine. Read More Anti-Aging Treatments We provide compassionate health care combined with advanced medical and technical expertise. Our patient-focused, multi-lingual (Russian, English, Greek) health care team collaborates with selected experts and consultants who specialize in: Gynaecology, Family Medicine, Child Care, Breast Health, Anti-aging Treatments, Preventive Medicine, Plastic Surgery, Aesthetic Medicine, Complementary Medicine, and Alternative medicine. Read More Aesthetic Medicine We provide compassionate health care combined with advanced medical and technical expertise. Our patient-focused, multi-lingual (Russian, English, Greek) health care team collaborates with selected experts and consultants who specialize in: Gynaecology, Family Medicine, Child Care, Breast Health, Anti-aging Treatments, Preventive Medicine, Plastic Surgery, Aesthetic Medicine, Complementary Medicine, and Alternative medicine. Read More Preventive Medicine We provide compassionate health care combined with advanced medical and technical expertise. Our patient-focused, multi-lingual (Russian, English, Greek) health care team collaborates with selected experts and consultants who specialize in: Gynaecology, Family Medicine, Child Care, Breast Health, Anti-aging Treatments, Preventive Medicine, Plastic Surgery, Aesthetic Medicine, Complementary Medicine, and Alternative medicine. Read More Health News & Advice Polyps, Ovarian Cysts and Myomasion Date: 24 November 2023 New protocols to address all gynecological malformations as re-occurrence of ovarian cysts, myoma noodles or breast cysts with bio- identical progesterone. The old approach with synthetic hormones do increase cancer risk if prescribed as a long protocol which is most often given for above-mentioned conditions. The bio-identical progesterone is exactly the one as human body produces, so the correct replacement just provides the right hormone balance and protects from cervical and endometrial polyps, breast cyst and myomas. More Health News & Advice Advanced medical expertise delivered with compassionate care. Who Are We? Who Are We? Our Team Our Team Our Team Our Team Contact Search Results

GYNECOLOGIST . OBSTETRICIAN . IN VITRO FERTILISATION DNA METABOLISM . ANTI-AGING TREATMENTS PREVENTIVE MEDICINE COOKIE POLICY The Cookie Policy of Relikor Serv Ltd, explains what cookies are and how we use them, the types of cookies we use i.e, the information we collect using cookies and how that information is used, and how to control the cookie preferences. For further information on how we use, store, and keep your personal data secure, see our Privacy Policy. You can at any time change or withdraw your consent from the Cookie Declaration on our website. What are cookies ? Cookies are small text files that are used to store small pieces of information. They are stored on your device when the website is loaded on your browser. These cookies help us make the website function properly, make it more secure, provide better user experience, and understand how the website performs and to analyze what works and where it needs improvement. How do we use cookies ? As most of the online services, our website uses first-party and third-party cookies for several purposes. First-party cookies are mostly necessary for the website to function the right way, and they do not collect any of your personally identifiable data.The third-party cookies used on our website are mainly for understanding how the website performs, how you interact with our website, keeping our services secure, providing advertisements that are relevant to you, and all in all providing you with a better and improved user experience and help speed up your future interactions with our website. What types of cookies do we use ? Essential Some cookies are essential for you to be able to experience the full functionality of our site. They allow us to maintain user sessions and prevent any security threats. They do not collect or store any personal information. For example, these cookies allow you to log-in to your account and add products to your basket, and checkout securely. Statistics These cookies store information like the number of visitors to the website, the number of unique visitors, which pages of the website have been visited, the source of the visit, etc. These data help us understand and analyze how well the website performs and where it needs improvement. Marketing Our website displays advertisements. These cookies are used to personalize the advertisements that we show to you so that they are meaningful to you. These cookies also help us keep track of the efficiency of these ad campaigns.The information stored in these cookies may also be used by the third-party ad providers to show you ads on other websites on the browser as well. Functional These are the cookies that help certain non-essential functionalities on our website. These functionalities include embedding content like videos or sharing content of the website on social media platforms. Preferences These cookies help us store your settings and browsing preferences like language preferences so that you have a better and efficient experience on future visits to the website. How can I control the cookie preferences ? Should you decide to change your preferences later through your browsing session, you can click on the “Privacy & Cookie Policy” tab on your screen. This will display the consent notice again enabling you to change your preferences or withdraw your consent entirely. In addition to this, different browsers provide different methods to block and delete cookies used by websites. You can change the settings of your browser to block/delete the cookies. Advanced medical expertise delivered with compassionate care. Who Are We? Who Are We? Our Team Our Team Our Team Our Team Contact Search Results

GYNECOLOGIST . OBSTETRICIAN . IN VITRO FERTILISATION DNA METABOLISM . ANTI-AGING TREATMENTS PREVENTIVE MEDICINE PRIVACY POLICY PRIVACY POLICY STATEMENT Relikor is committed to protecting privacy of clients and associates. The Privacy Policy presented below aims to inform you about the nature of the personal information that is processed by our Company and the rights and options you have in this respect. It also describes how we collect, handle, use, and disclose your personal information obtained through our website and social media pages. This Privacy Policy Statement replaces any previous Privacy Policy Statement or equivalent which you may have been provided with prior to the Last Modified Date stated above. This policy statement is effective 1st November 2021 and may be changed at any time. THE PRIVACY POLICY STATEMENT IS AS FOLLOWS: Relikor Serv Ltd (in this Privacy Policy, “us”, “we” and “our”) is the data controller of your personal data and is subject to the EU General Data Protection Regulation 2016/679 (the “GDPR”). Privacy and Data Compliance Officer’s contact details are as follows: Email: info@relikor.com Telephone: +357 22025795 YOUR RIGHTS Under the EU GDPR DIRECTIVE you have the following rights: • To instruct us to cease processing your personal data if the processing is causing you damage or distress; • To gain access to, and copies of, the personal data that we hold about you; • To instruct us not to send you marketing communications; • To instruct us to restrict our data processing activities; • To instruct us to erase your personal data; • To obtain from us the personal data we hold about you which you have provided to us, in a practical format specified by you, including for the purpose of you transmitting that personal data to another data controller; • To instruct us to correct the personal data we hold about you if it is incorrect. Please note that the above rights are not absolute, and we may be titled to refuse requests where exceptions apply. You may find out more about your rights at the website of the Office of the Commissioner for Personal Data Protection at www.dataprotection.gov.cy or by contacting us. If you are not satisfied with how we are processing your personal data, you can make a complaint to Commissioner for Personal Data Protection of the Republic of Cyprus HOW WE COLLECT YOUR DATA We collect your personal data in multiple ways, for example in following ways: • From the material you provide to us when you meet us; • When you communicate with us by telephone, fax, email or other forms of electronic communication. In this respect, we may monitor, record and store any such communication; • When you complete (or we complete on your behalf) client engagement forms or any other forms; • From other affiliated companies of ours; • From your agents, advisers and intermediaries; • From publicly available sources or from third parties. CATEGORIES OF PERSONAL DATA WE COLLECT We collect the following categories of personal data about you through our Website: • Your name and contact information such as your home or business address, email address and telephone and fax number; • Biographical information which may confirm your identity including your date of birth, tax identification number, VAT number, reference letters, CV, ARC, passport number, driver’s license or national identity card details, country of domicile and/or your nationality; • Information relating to your financial situation such as income, expenditure, assets and liabilities, sources of wealth, as well as your bank account details; • An understanding of your goals and objectives in our services; • Information to assess whether you may be characterized as a politically exposed person or a person involved in terrorist financing/ money laundering. • Information that you provide by filling in forms, in particular at the time of the first contact with us. • We also collect Personal Information when you enter a contest or promotion sponsored by us, and when you report a problem with our Website. • Records and copies of your correspondence (including e-mail addresses), if you contact us. • Details of transactions you carry out, if any, and of the fulfilment of your orders. WHY WE COLLECT YOUR DATA AND HOW WE USE YOUR DATA The rationale behind the processing of your personal data (other than with your consent), the use of that personal data and whom we share it with: (i) Performance of a contract with you We process your personal data in the course of the performance of a contract to which you are a party or in order to take steps at your request prior to entering into a contract. In this respect, we use your personal data for the following: • To prepare a quotation for you with respect to the services we offer; • To provide you with the services as set out in our Engagement Letter with you or as otherwise agreed with you from time to time; • To deal with any complaints or feedback you may have; • For any other purpose for which you provide us with your personal data. In this respect, we may share your personal data with or transfer it to the following: • Your agents, advisers, intermediaries, and custodians of your assets who you tell us about; • Third parties whom we engage to assist in delivering the services to you, including our affiliated companies; • Our professional consultants where it is necessary for us to obtain their advice or assistance, including lawyers, accountants, or IT; • Other third parties such as intermediaries who we introduce to you. We will wherever possible tell you who they are before we introduce you; • Our data storage providers. (ii) Legal obligations We also process your personal data for our compliance with a legal obligation which we are under. In this respect, we will use your personal data for the following: • To meet our compliance and regulatory obligations, such as compliance with anti-money laundering and anti-terrorist financing laws; • As required by tax authorities or any competent court or legal authority. In this respect, we will share your personal data with the following: • Our consultants where it is necessary for us to obtain their advice or assistance; • Our auditors where it is necessary as part of their auditing functions; With relevant regulators or law enforcement agencies where we are required to do so. (iii) Legitimate interests We also process your personal data because it is necessary for our legitimate interests, or sometimes where it is necessary for the legitimate interests of another person. In this respect, we use your personal data for the following: For the administration and management of our business, including recovering money you owe to us, and archiving or statistical analysis; Seeking advice on our rights and obligations, such as where we require our own legal advice; In this respect we will share your personal data with the following: Our advisers or agents where it is necessary for us to obtain their advice or support; With third parties and their advisers where those third parties are acquiring, or considering acquiring, all or part of our business. MARKETING INFORMATION We may send you marketing information about similar services we provide, as well as other information in the form of e-mails and invitations to events which we believe might be of interest to you. We may communicate this to you in a number of ways including by telephone or email. If you object to receiving marketing from us at any time, please contact us by email (info@relikor.com ). TRANSFER AND PROCESSING OF YOUR DATA OUTSIDE THE EUROPEAN UNION When sharing your personal data with third parties as set out in this Privacy Policy, it may be transferred outside the European Union. In these circumstances, your personal data will only be transferred on one of the following bases: the country that we send the personal data to is approved by the EU as providing an adequate level of protection for personal data; the transfer is to a recipient in the USA who has registered under the EU/US Privacy Shield; when you have explicitly consented to the same. RETENTION OF YOUR PERSONAL DATA Where we have collected your personal data as required by anti-money laundering legislation, including for identification, screening and reporting, we will retain that personal data for five years after the termination of our business relationship, unless we are required to retain this information by another law or for the purposes of court proceedings. CHANGES TO OUR PRIVACY POLICY We may modify our privacy policy from time to time and although we may attempt to notify you, you are expected to periodically review the most up-to-date version found at our website www.sclaw.com.cy so you are aware of these binding changes. When we amend our privacy policy, the “Last Modified Date” will be changed, therefore you agree that you will review this privacy policy from time to time and refresh the page when doing so. If the “Last Modified Date” has not been changed from the last time you have revised our privacy policy, then it is unchanged. On the other hand, if the date has changed, then there have been changes, and you agree to re-review our privacy policy, and you agree to the new ones. By continuing to use the Website subsequent to us making available an amended version of our privacy policy in a way that you can easily take notice of it, you hereby consent to such amendment. NO RIGHTS OF THIRD PARTIES This privacy policy does not create rights enforceable by third parties or require disclosure of any Personal Information relating to users of the Website. NO ERROR FREE PERFORMANCE We do not guarantee error-free performance under this privacy policy and we shall not be liable for any incidental, consequential or punitive damages relating to this privacy policy. Advanced medical expertise delivered with compassionate care. Who Are We? Who Are We? Our Team Our Team Our Team Our Team Contact Search Results

CONTACT US If you would like more information about our services, call +357 22324632 or please fill in the form below and click 'SUBMIT'. First Name Last Name Email Address Phone Message SUBMIT Thank you for sending us your enquiry. We guarantee that all communications with clients is strictly confidential. Who Are We? Who Are We? Our Team Our Team Our Team Our Team Contact Search Results

GYNECOLOGIST . OBSTETRICIAN . IN VITRO FERTILISATION DNA METABOLISM . ANTI-AGING TREATMENTS PREVENTIVE MEDICINE NEWS & UPDATES New Protocol for Polys, Ovarian Cysts and Myomasion Date: 24 November 2023 New protocols to address all gynecological malformations as re-occurrence of ovarian cysts, myoma noodles or breast cysts with bio- identical progesterone. The old approach with synthetic hormones do increase cancer risk if prescribed as a long protocol which is most often given for above-mentioned conditions. The bio-identical progesterone is exactly the one as human body produces, so the correct replacement just provides the right hormone balance and protects from cervical and endometrial polyps, breast cyst and myomas. Read More New Protocol for Polys, Ovarian Cysts and Myomasion Date: 24 November 2023 New protocols to address all gynecological malformations as re-occurrence of ovarian cysts, myoma noodles or breast cysts with bio- identical progesterone. The old approach with synthetic hormones do increase cancer risk if prescribed as a long protocol which is most often given for above-mentioned conditions. The bio-identical progesterone is exactly the one as human body produces, so the correct replacement just provides the right hormone balance and protects from cervical and endometrial polyps, breast cyst and myomas. Read More Health News & Advice Polyps, Ovarian Cysts and Myomasion Date: 24 November 2023 New protocols to address all gynecological malformations as re-occurrence of ovarian cysts, myoma noodles or breast cysts with bio- identical progesterone. The old approach with synthetic hormones do increase cancer risk if prescribed as a long protocol which is most often given for above-mentioned conditions. The bio-identical progesterone is exactly the one as human body produces, so the correct replacement just provides the right hormone balance and protects from cervical and endometrial polyps, breast cyst and myomas. More Health News & Advice Advanced medical expertise delivered with compassionate care. Who Are We? Who Are We? Our Team Our Team Our Team Our Team Contact Search Results

OFFICIAL REGISTRY FOR PROPERTIES IN CYPRUS USED FOR SHORT-TERM RENTALS After a lot of pressure from organisations representing hotel owners and property owners renting properties for long term rentals, who were claiming unfair competition and tax-evasion. Now there is a new law to regulate this sector of the hospitality industry. All property owners in Cyprus who are renting accommodation for short-term rentals must register their details in the official Registry. ​ The De puty Ministry of Tourism announced that all self-catering accommodations rented on online platforms such as AIRBNB, BOOKING.COM and others, should be registered in the relevant registry of the Deputy Ministry by 06/02/2023. According to the relevant legislation, in order to be able to advertise and/or rent the self-catering accommodation, applicants must have a special mark and registration number from the Deputy Ministry which should be indicated on each platform where the accommodation is advertised. The registration fee for a self-catering accommodation is €222 for every three years. ​ Also note that all income from the rental of self-catering accommodation is subject to Income Tax, VAT and fees payable to the Local Authorities. FInally note that officials of t he Deputy Ministry of Tourism have the authority to check any self-catering accommodation, to verify the existence of a registration permit, as well as the compliance by the owner with the terms of registration of the accommodation. ​ For more information and registration go to the Deputy Ministry of Tourism page ​ ​ DECISION BY EUROPEAN COURT OF JUSTICE DATED 22 NOVEMBER 2022 ​ After the debate of whether AML regulations can come in conflict with GDPR regulations for EU citizens, the European Court of Justice issued a judgment dated 22/11/2022 that (quoted from the press release) “…the general public’s access to information on beneficial ownership constitutes a serious interference with the fundamental rights to respect for private life and to the protection of personal data…” ​ Therefore (quoted from the press release) “….. the provision of the anti-money-laundering (AML) Directive whereby Member States must ensure that the information on the beneficial ownership of corporate and oth er legal entities incorporated within their territory is access ible in all cases to any member of the general public is invalid” The aforementioned ruling concludes that granting public access to UBO Registers of European companies is no longer valid, since it constitutes a serious intervention regarding fundamental rights of respect for privacy and the protection of personal data ( see Articles 7 and 8, Charter of Fundamental Rights of the European Union). The relevant information shall be provided to the competent and supervisory authorities as well as to the obliged entities via the applicable procedure. It is imperative that obliged entities submit a solemn declaration to confirm that such information is requested for the purpose of due diligence. Companies and partnerships are still obligated to submit updated Beneficial Owners information. After this landmark decision, our Firm is waiting for further instructions and clarifications from the Cyprus Registrar of Companies before we inform our clients respectively on how to proceed regarding their personal data submitted to the Cyprus UBO Registry. REPORTING DEADLINE FOR DEEMED DIVIDEND DISTRIBUTION (DDD) The Deemed Dividend Distribution (DDD) provisions apply to the profits of Cyprus tax resident companies, that are attribut able directly or indirectly to Cyprus tax resident and domiciled shareholders. The provisions do not apply to the portion of profits attributable directly or indirectly to non-Cyprus tax resident and/or Cyprus tax resident non-domiciled shareholders, although, there is an obligation to withhold GHS contributions on any DDD attributable to Cyprus tax resident non-domiciled shareholders. ​ Companies are deemed to have distributed to their resident shareholders 70% of their accounting profits, after taxes and certain adjustments, as at the end of two years from the year to which the profits relate to. Therefore, the DDD provisions apply where a Cyprus company has not distributed at least 70% of its after-tax accounting profits (as adjusted for DDD purposes) within the two-year period. Any actual dividends paid out of such profits within the two-year period reduce the profits subject to the deemed distribution rules. According to the DDD provisions set above, companies with accounting profits for the tax year 2020, which have not distributed at least 70% of their adjusted after-tax profits before the 31st of December 2022, are subject to the DDD provisions.The undistributed part of the profits after tax (as adjusted for DDD purposes), up to the 70% threshold, is subject to SDC at 17% for Cyprus tax resident domiciled shareholders. ​ GHS Contributions In addition to the SDC, the distribution of a deemed dividend to shareholders which are Cyprus tax resident individuals (irrespective of their domicile status) may be subject to contributions to the General Healthcare Scheme (GHS) at the rate of 2,65%. Payment deadlines For SDC and GHS contributions on DDD as at 31st December 2022, the payment is due by the 31st of January 2023. The payments are made through JCC smart or online banking. In case of late payments, these can be made only through online banking and are subject to interest at the current rate of 1,75% per annum and to a 5% penalty on the tax due. An additional penalty of 5% on the tax due may be imposed if the tax remains unpaid two months after the above due dates. T ax return submission d eadline For DDD as at 31st of December 2022 with SDC and GHS liability, the “Declaration of withheld Special Contribution for Defence (SDC) and General Healthcare Scheme (GHS) from Dividends” (i.e., form T.D.603) should be submitted through the Taxisnet electronic system by the 31st of January 2023. Late submission carries a fixed penalty ​ ​ Please contact us should you require further assistance with the above. Cyprus Companies benefit from increased tax deduction for R & D expenses On July 7th, the Cyprus Parliament voted for an extension of tax incentives (an action plan that was voted on in October 2021) in an attempt to attract new investments, boost entrepreneurship and support start-ups. This regards an incorporation of tax deduction on research and development expenses into Article 9(1)(d) of the Income Tax Law (ITL) and is effective as of July 20th 2022 when it was published in the Cyprus Gazette. ​ The existing article 9(1)(d) of the Income Tax Law states that: " Any expenditure for scientific research incurred by a person carrying on any business, as well as R&D expenses as recognized by international accounting standards carried out by small and medium-sized innovative companies as defined in Article 9A of the ITL, shall be deducted from taxable income if they were wholly and exclusively incurred for the production of income, so long as the Commissioner is satisfied that such expenditure has been incurred for the use and benefit of the business. No deduction shall be granted for such expenses incurred for the acquisition of plant and machinery or buildings, including staff accommodation, in respect of which a deduction may be granted according to Article 10 of the ITL. Any such expenditure of a capital nature, in respect of which deductions may not be granted under Article 10, shall be distributed equally between the tax year in which it was incurred and the five immediately following years." According to the aforementioned amendments, a n additional tax deduction of 20% is granted for R&D expenses that have incurred or will incur during 2022,2023 or 2024, including expenses of capital nature, for which deduction is granted under the provisions of article 9(1)(d) of ITL. Hence, 120% of the actual eligible R&D expenses are to be deducted from taxable income. It is important to note that the additional deduction cannot be claimed in conjunction with the deduction provided under the Cyprus IP regime (article 9(1)(k) of the ITL). Provisions include individuals carrying on a business who do have the economic ownership of the intangible asset that arises or is likely to arise from incurring such expenses. Should the relevant expenses are of capital nature, the deduction is regulated by the provisions of Section 9(1)(l) of the ITL, which states that the expense is distributed over the expected life duration of the intangible asset, with a maximum period of 20 years, according to accepted accounting principles. We are at your disposal should you require further assistance with the above. ​